Nippon Express Secures GDP certification for 2 pharmaceutical centres

KUALA LUMPUR, Feb 10 (Bernama) -- Nippon Express Co Ltd (Nippon Express) has acquired Good Distribution Practice (GDP) certification for its West Japan Pharmaceutical Center and Kyushu Pharmaceutical Center to demonstrate its compliance with World Health Organisation (WHO) standards for the proper distribution of pharmaceuticals.

In a statement, Nippon Express, a group company of Nippon Express Holdings Inc said former certification is effective Nov 20, 2022, and the latter Dec 21, 2022.

The West Japan Pharmaceutical Center located in Neyagawa City, Osaka Prefecture and the Kyushu Pharmaceutical Center in Kitakyushu City, Fukuoka Prefecture are dedicated logistics bases for pharmaceuticals.

Both centres obtained GDP certification of their conformity to WHO standards for the storage and transport of pharmaceutical products in two temperature ranges (room temperature “15 C - 25 C” and refrigerated “2 C - 8 C”).

It is the same certification that the East Japan Pharmaceutical Center in Kuki City, Saitama Prefecture acquired in July last year.

The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its “Nippon Express Group Business Plan 2023 -- Dynamic Growth”, and has been developing a safe and secure pharmaceutical logistics platform to meet sophisticated and diverse pharmaceutical logistics needs globally.

Currently, the Nippon Express Group has 34 business locations in 24 countries/regions worldwide with GDP, CEIV Pharma or other certifications for pharmaceutical logistics, helping the group better provide safe and high-quality pharmaceutical logistics services on an end-to-end basis globally.

-- BERNAMA